...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: And we wait.....

hummmmmmmm,,,they sit beside my B549794 Bre-X shares for now,,,,,I assume cuz they mirror eachother,,, :o) ,,,,but nice try there big fella,,,,its the time factor which I assume is partially based or more wholly on 208 being the draft horse for the ZENs!!!And we all know Zen is a form of Buddhism with lots of meditation involved,,,and that must mean we need to have patience with lots of idle time on our hands.

I again assume ZEN Cap and ZEN Epi will be in the cross hairs by our big insiders if 208 makes its' mark,,,,and of course if ZEN-3694 hits in oncology...........just a brain fart which is still just an opinion,,,which again each of have one!!,,,,I am certainly a poor investor,,,,,may have to try my hand at a different trade!!!,,, Maybe Ill run some international conferences!!!,,  :o)

Share
New Message
Please login to post a reply